Literature DB >> 9864027

Chylothorax or leakage of total parenteral nutrition?

A Wolthuis1, R B Landewé, P H Theunissen, L W Westerhuis.   

Abstract

The diagnosis chylothorax is based on a chemical analysis of the pleural effusion. According to the literature, this analysis can be rather straightforward, comprising measurements of triglycerides, chylomicrons, and cholesterol. In this report we present an autopsy case that alerted us to interpret these results critically. Although the laboratory tests of the pleural effusion in this patient with parenteral nutrition suggested chylothorax, additional tests (potassium (11.3 mmol.L(-1)) and glucose (128 mmol.L(-1)) proved otherwise. Comparison of the pleural effusion analysis and the content of the parenteral nutrition led to the final conclusion that the effusion was due to a leakage of parenteral nutrition instead of chylothorax. We therefore suggest adding glucose and potassium measurements to the biochemical work-up of a patient under suspicion of chylothorax.

Entities:  

Mesh:

Year:  1998        PMID: 9864027     DOI: 10.1183/09031936.98.12051233

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  [Bilateral hydrothorax and hydromediastinum after puncture of the right subclavian vein].

Authors:  R Wildenauer; P Kobbe; C Waydhas
Journal:  Unfallchirurg       Date:  2009-01       Impact factor: 1.000

2.  Pleural effusion in a neonate.

Authors:  Sandeep Krishnanand Shetty; Mark Butler
Journal:  BMJ Case Rep       Date:  2011-08-11

3.  Bilateral total parenteral nutrition pleural effusions in a 5-week-old male infant.

Authors:  Christopher Flannigan; Thomas Bourke; Karen Keown; Mark Terris
Journal:  BMJ Case Rep       Date:  2012-07-03

4.  Extravasation of TPN following central venous catheter migration.

Authors:  SungMin Hong; Sung Hyun Kim; Hyun-Kyung Lee; Young-Min Lee; Mi-Yeong Kim; Hongyeul Lee; Ho-Young Lee
Journal:  Respir Med Case Rep       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.